Search

Search Results

• Gender Differences in Depression and Anxiety in Parkinson’s Disease

  Gabriel Ortiz-Genaro, Héctor González-Usigli, Fermín Paul Pacheco-Moisés, Irma Ernestina Velázquez-Brizuela, Angélica Lizeth Sánchez-López, Erika Daniela González-Renovato, Aidé Irene Mesa-Acuña, Blanca Miriam Torres-Mendoza, Daniela Lucero Delgado-Lara

  51-60

  2020-03-01

• Current Knowledge and Future Directions in Huntington’s Disease

  Eileeng Morales, Camila Herrera , Ledys Montaño , Karin Martínez, María Meza, Natalia Del Villar, Xilene Mendoza, Alexander Rodríguez

  2022-05-31

• Comparative review of central post-stroke and other causes of CNS-originated pain: pathophysiology and treatment

  A Quintero-Villegas, MO Valenzuela-Almada, HS Álvarez-Manzo, J Calleja-Castillo

  6-24

  2020-05-17

• Dopamine for beginners

  Hazael Avila-Rojas, Iván Pérez-Neri

  55-57

  2017-03-01

• Metabolism and effect of dehydroepiandrosterone (DHEA) in the central nervous system

  Miguel Ángel Márquez-Flores , Hugo Sandoval , Iván Pérez-Neri, Camilo Ríos, Carlos Eduardo Diéguez-Campa

  51-58

  2020-10-14

• Advances in preclinical research of the C-Terminal domain of the heavy chain of the tetanic toxin in neurodegenerative diseases

  Irving Parra, Isabel Martínez, Félix Luna, Victorino Alatriste, Daniel Limón, Liliana Mendieta

  61-76

  2020-03-01

• Leptin and its role in the neuroendocrinology of obesity

  Carlos Eduardo Diéguez-Campa, Jorge Castillo Ledón-Pretellini, Jesús Alejandro de los Santos-Coyotl, Luis I. Angel-Chávez, Iliana Arely Flores-Apodaca, Iván Pérez-Neri

  2022-05-24

• Nitric oxide participation in schizophrenia: the debate between the brain and the rest of the body

  Iván Pérez-Neri

  2016-09-01

• Immunity in autoimmune diseases

  Martin Eduardo Torres-Velasco , Signe María Gómez-Hollsten , Esteban Uriel Montes-Moratilla , Laura Virginia Adalid-Peralta

  59-69

  2020-10-15

• Gestational exposure to Toxoplasma gondii antigens induces cognitive alterations in adult rats by reducing glutamate and dopamine levels and elevating KYNA levels in hippocampus.

  Alma Acosta Ramírez, Tonali Blanco Ayala, Eunice Romero Núñez, Saé Muñiz-Hernández, Verónica Pérez de la Cruz

  2024-04-23

• Non-pharmacological intervention on inhibitory control in adolescents with ADHD

  Daniel Hernández Torres, Alma Licona Oliver

  2021-03-05

• Metabolic sindrome and Parkinson’s disease

  Margarita Gómez-Chavarín , Ma. del Rocío Morales-Gómez

  34-44

  2020-07-31

• Evaluation of the antioxidant effect of olanzapine in combination with N Acetyl Cysteine in a mouse model of schizophrenia induced by MK-801.

  Reyna Lamas-Aguilar, Iván Pérez-Neri, Camilo Rios, Alfonso Mata-Bermúdez, Erick Martínez, Norman Manning, Araceli Diaz-Ruiz

  2022-11-24

• Overview of schizophrenia

  Iván Pérez-Neri

  213-216

  2015-09-01

• EXPRESSION OF DOPAMINE RECEPTORS IN ACTIVATED CD4+ CD8+, CD19+ AND CD11C+ POPULATIONS AFTER TREATMENT WITH PRAMIPEXOL IMPLICATIONS FOR PARKINSON'S DISEASE

  Edwin Jafet Gallegos Altamirano, Erandi Pérez Figueroa, Laura Adalid-Peralta

  2024-04-23